JPRN-UMIN000001886已完成未知
A multicenter observational study of clinical relevance of microalbuminuria and intra-renal RAS in type 2 diabetes. - Clinical relevance of diabetic complications and intra-renal RAS in type 2 diabetes.
Kagawa University, Faculty of Medicine0 个研究点目标入组 300 人开始时间: 2009年4月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes mellitus 2) Pregnancy 3) Severe renal disease (Proteinuria, CCr<50 mL/min, sCr >= 1.5 mg/dL) 4) Severe hepatic disease (GOT >= 150 IU or GPT >= 150 IU) 5) Endocrine disease 6) Patients with malignant tumor 7) Patients inadequate for the study
研究者
相似试验
招募中
不适用
Multi-center observational study to investigate the effect of immune checkpoint inhibitors on MSI-H/dMMR solid tumorsMSI-H/dMMR solid tumorJPRN-UMIN000044728ational Cancer Center200
已完成
不适用
A multi-center retrospective observational study in patients with relapsed and refractory multiple myeloma receiving once-weekly carfilzomib dosing in combination with dexamethasone in a real-world setting in Japan (Weekly-CAR study)Multiple myelomaJPRN-UMIN000043049Ono Pharmaceutical Co., Ltd.150
已完成
4 期
A prospective, observational, multi-centre study investigating alterations of gut microbiome with its subsequent interaction on the brain-immune-intestine axis in patients with active relapsing remitting Multiple Sclerosis who start with oral treatment.10029305multiple sclerosisNL-OMON54765Sint Elisabeth Ziekenhuis72
招募中
Unknown
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206
已完成
不适用
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancerJPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850